Literature DB >> 22677468

Identification of possible risk factors for the development of dopamine agonist withdrawal syndrome in Parkinson's disease.

Anne-Louise Cunnington, Lesley White, Kay Hood.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22677468     DOI： 10.1016/j.parkreldis.2012.05.012

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN： 1353-8020            Impact factor:   4.891


× No keyword cloud information.
  11 in total

1.  Factors to Consider in the Selection of Dopamine Agonists for Older Persons with Parkinson's Disease.

Authors:  Mark Dominic Latt; Simon Lewis; Olfat Zekry; Victor S C Fung
Journal:  Drugs Aging       Date:  2019-03       Impact factor: 3.923

2.  A Pilot Prospective, Multicenter Observational Study of Dopamine Agonist Withdrawal Syndrome in Parkinson's Disease.

Authors:  Kallol Ray Chaudhuri; Antoniya Todorova; Melissa J Nirenberg; Miriam Parry; Anne Martin; Pablo Martinez-Martin; Alexandra Rizos; Tove Henriksen; Wolfgang Jost; Alexander Storch; Georg Ebersbach; Heinz Reichmann; Per Odin; Angelo Antonini
Journal:  Mov Disord Clin Pract       Date:  2015-03-16

Review 3.  Management of impulse control disorders in Parkinson's disease: Controversies and future approaches.

Authors:  Michael Samuel; Maria Rodriguez-Oroz; Angelo Antonini; Jonathan M Brotchie; Kallol Ray Chaudhuri; Richard G Brown; Wendy R Galpern; Melissa J Nirenberg; Michael S Okun; Anthony E Lang
Journal:  Mov Disord       Date:  2015-01-21       Impact factor: 10.338

Review 4.  Dopamine agonist withdrawal syndrome: implications for patient care.

Authors:  Melissa J Nirenberg
Journal:  Drugs Aging       Date:  2013-08       Impact factor: 3.923

Review 5.  Impulse control disorders in Parkinson's disease: an overview from neurobiology to treatment.

Authors:  Emke Maréchal; Benjamin Denoiseux; Ellen Thys; David Crosiers; Barbara Pickut; Patrick Cras
Journal:  J Neurol       Date:  2014-05-14       Impact factor: 4.849

6.  Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease.

Authors:  Kara M Smith; Sharon X Xie; Daniel Weintraub
Journal:  J Neurol Neurosurg Psychiatry       Date:  2015-11-03       Impact factor: 10.154

Review 7.  The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.

Authors:  Amy T Page; Rhonda M Clifford; Kathleen Potter; Darren Schwartz; Christopher D Etherton-Beer
Journal:  Br J Clin Pharmacol       Date:  2016-06-13       Impact factor: 4.335

8.  A Case Report of Severe Delirium after Amantadine Withdrawal.

Authors:  Franz Marxreiter; Jürgen Winkler; Martin Uhl; Dominik Madžar
Journal:  Case Rep Neurol       Date:  2017-03-20

Review 9.  Neuropsychiatric symptoms in untreated Parkinson's disease.

Authors:  Szabolcs Szatmari; Ben Min-Woo Illigens; Timo Siepmann; Alexandra Pinter; Annamaria Takats; Daniel Bereczki
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-16       Impact factor: 2.570

Review 10.  Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies.

Authors:  Jun-Fang Zhang; Xi-Xi Wang; Ya Feng; Robert Fekete; Joseph Jankovic; Yun-Cheng Wu
Journal:  Front Psychiatry       Date:  2021-02-09       Impact factor: 4.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.